TET2 and angioimmunoblastic T-cell lymphoma: Additionally, AITL exhibits a unique genetic profile, frequently harboring specific driver mutations like IDH2R172K and RHOAG17V, as well as mutations in epigenetic regulatory genes, such as TET2 and DNMT3A, and T-cell receptor (TCR)-related genes (1, 5, 12).